Publications Details

Home / Our Technology / Scientific Publications / Publications Details

View all news

Divesiran, A Novel GalNAc Conjugated siRNA, Reduces Phlebotomies, Improves Iron Stores and Symptoms in Polycythemia Vera Patients in SANRECO Phase 1 Study

06/11/2026

DownloadPDF Format (opens in new window)PDF 660 KB

Multimedia Files:

View all news

Stay Connected

Quick Links

About Us
Our Pipeline
Our Technology
Patients
Investors

Contact

Corporate Headquarters

United Kingdom
12 Hammersmith Grove
London, W6 7AP

United States
221 River Street
9th Floor
Hoboken, NJ 07030

Germany
Robert-Rossle-Str. 10
D-13125 Berlin
+49 30 9489 2800

Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Silence Therapeutics, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Silence Therapeutics to send you the requested Investor Email Alert updates.

* Required

Email Address *

Unsubscribe

Mailing Lists *

Press Releases

Events

Presentations

SEC Filings

End of Day Stock Quote

Email Alert Sign Up Confirmation

Stay Connected

Cookie Preferences

Terms of Use
Privacy and Cookie Notice